News
GDNF clinical trial results in 2019 revealed signs that GDNF may make it possible to repair the cells damaged in people with Parkinson’s. We take a look at where we are 1 year later.
Over the next few months we plan to share who we are and what we’re doing for the charity. We hope you’ll get to know us better and we’ll know more about you.
A promising molecule, called BT13, has offered hope for a new treatment that could stop or slow Parkinson’s, something no treatment can currently do.
On Sunday 19 January, Jeremy Vine presents the BBC Lifeline Appeal on behalf of Parkinson’s UK.
New research suggests that a bacteria which boosts digestive health can slow – and even reverse – the build-up of a protein associated with Parkinson’s.
In our survey of more than 2,000 people, more than a quarter (26%) reported they were misdiagnosed with a different condition before receiving the correct Parkinson’s diagnosis.
we announce the winners of our first volunteer awards
2019 was another exciting year of progress. Here are 8 of the highlights, and 8 ways you can still get involved.
Researchers, funded by Parkinson's UK, have produced positive results in mice for a gene therapy treatment that directly targets the production of the alpha-synuclein protein.
Survey we supported shares findings that people with advanced or terminal illness support a change in the law on assisted dying